Synergy Pharma (SGYP) Announces Presentation of Additional Plecanatide Phase 3 Data in CIC
Tweet Send to a Friend
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced additional data from two pivotal phase 3 clinical trials (Study-00 and Study-03) evaluating the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
